Phio Pharmaceuticals Corp (PHIO) Stock Analysis

Phio Pharmaceuticals Corp (PHIO) is a publicly traded company in the HEALTHCARE sector. It trades at $1.12, carries a market capitalization of $13.13M. This page summarizes the public market data, fundamentals, and frequently asked questions for PHIO, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.12
• Market Cap: $13.13M
• EPS: $-1.38
• 52-Week High: $3.48
• 52-Week Low: $0.81

Market Sentiment

Phio Pharmaceuticals Corp currently has a Bullish sentiment score of 0.34.

About Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corp. is a biotechnology firm based in Marlborough, Massachusetts, focused on developing groundbreaking therapeutics that harness the power of the immune system to combat cancer. Utilizing its proprietary self-delivering RNA interference (RNAi) technology, the company aims to create transformative treatments that enhance efficacy while minimizing adverse effects. With a strong pipeline of innovative product candidates, Phio is well-positioned to play a significant role in...

GNG Research Analysis

GNG Research scores Phio Pharmaceuticals Corp (PHIO) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PHIO.

Frequently Asked Questions

Does PHIO pay dividends?

Phio Pharmaceuticals Corp (PHIO) does not currently pay a regular dividend.

What is PHIO's market cap?

Phio Pharmaceuticals Corp (PHIO) has a market capitalization of $13.13M with a current stock price of $1.12.